NICOLE CAVIGNARO: Open Payments
NPI 1508527748 · ST AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,071 in 70 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $1,812 · 2025 $1,071
Food & beverage: $971Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $285 |
| ABBVIE INC. | 15 | $197 |
| Regeneron Healthcare Solutions, Inc. | 9 | $172 |
| GENZYME CORPORATION | 7 | $139 |
| Organon LLC | 15 | $106 |
| PFIZER INC. | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Galderma Laboratories, L.P. | 2 | $37 |
| Almirall LLC | 1 | $20 |
| Amgen Inc. | 1 | $17 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, CIBINQO, VTAMA, RINVOQ, NEMLUVIO, COSENTYX.
Industry payments across FL — which companies pay providers there.
